MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 174 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2016. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $498,000 | -40.6% | 16,384 | -49.3% | 0.00% | -100.0% |
| Q1 2022 | $839,000 | -35.6% | 32,316 | -49.4% | 0.00% | 0.0% |
| Q4 2021 | $1,303,000 | -77.8% | 63,865 | -79.0% | 0.00% | -80.0% |
| Q3 2021 | $5,857,000 | -11.6% | 304,397 | +1.9% | 0.01% | -16.7% |
| Q2 2021 | $6,622,000 | -5.2% | 298,586 | +12.2% | 0.01% | -14.3% |
| Q1 2021 | $6,987,000 | +935.1% | 266,188 | +637.4% | 0.01% | +600.0% |
| Q4 2020 | $675,000 | -15.9% | 36,100 | -23.7% | 0.00% | 0.0% |
| Q3 2020 | $803,000 | -60.3% | 47,286 | -45.5% | 0.00% | -50.0% |
| Q2 2020 | $2,022,000 | +942.3% | 86,822 | +762.6% | 0.00% | – |
| Q3 2016 | $194,000 | -1.0% | 10,065 | 0.0% | 0.00% | – |
| Q2 2016 | $196,000 | -31.0% | 10,065 | -27.0% | 0.00% | – |
| Q1 2016 | $284,000 | – | 13,795 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acuitas Investments, LLC | 283,983 | $6,299,000 | 3.15% |
| Euclidean Technologies Management, LLC | 128,088 | $2,841,000 | 2.26% |
| GLOBEFLEX CAPITAL L P | 185,939 | $4,124,000 | 0.74% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,194,000 | 0.66% |
| CLARK ESTATES INC/NY | 220,000 | $4,880,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,424,274 | $31,590,000 | 0.56% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 789,827 | $17,518,000 | 0.53% |
| EARNEST PARTNERS LLC | 3,885,748 | $86,186,000 | 0.51% |
| MOODY ALDRICH PARTNERS LLC | 137,075 | $3,040,000 | 0.43% |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | 414,323 | $9,190,000 | 0.33% |